US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Arzol

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 12870-0001-02 D-1006-2022
Class II · Moderate risk Terminated

Olanzapine single dose vial Lyophilized

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0308-01 D-1005-2022
Class II · Moderate risk Terminated

Lidocaine Patch

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 42858-0118-30 D-1004-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0171-10 D-1002-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0250-50 D-1001-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0249-50 D-1000-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0170-30 D-0999-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-169-10 D-0998-2022
Class II · Moderate risk Terminated

Azithromycin for Injection USP Vial

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-174-10 D-0997-2022
Class II · Moderate risk Terminated

Topex

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0699-5116-01 D-0996-2022
Class II · Moderate risk Terminated

TobraDex

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0078-0876-01 D-0995-2022
Class II · Moderate risk Terminated

Miocol-E

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 24208-539-20 D-0994-2022
Class II · Moderate risk Terminated

Epi-Pen 2-Pak

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-500-02 D-0993-2022
Class I · High risk Terminated

Insulin Glargine

Reason Labeling: Missing label on the vial

Mylan Pharmaceuticals Inc NDC 49502-393-80 D-0845-2022
Class III · Low risk Terminated

Cyanocobalamin Injection

Reason Subpotent Drug: Out of specification for assay.

American Health Packaging D-0790-2022
Class II · Moderate risk Terminated

Losartan Potassium Tab. USP 50mg

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Preferred Pharmaceuticals, Inc. D-0789-2022
Class II · Moderate risk Terminated

Rifampin for Injection

Reason Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.

Mylan Pharmaceuticals Inc NDC 67457-445-60 D-0774-2022
Class II · Moderate risk Terminated

Losartan Potassium 50 mg Tablet

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

RemedyRepack Inc. NDC 70518-3282-1 D-0788-2022
Class II · Moderate risk Completed

Trulicity

Reason TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Cardinal Health Inc. NDC 0002-1433-80 D-0884-2022
Class II · Moderate risk Completed

Trulicity

Reason TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Cardinal Health Inc. NDC 00002-1434-80 D-0883-2022
Class I · High risk Completed

Humalog KwikPen

Reason TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Cardinal Health Inc. NDC 0002-8799-59 D-0882-2022
Class II · Moderate risk Terminated

Kill 'Dat Sanitizing Products Hand Sanitizer

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.

Lula Holdings L.L.C. NDC 77348-001-02 D-0859-2022
Class II · Moderate risk Terminated

Sermorelin Acetate 1 mg/mL

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0781-2022